No-touch technique in liver transplant for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial studies a surgical technique called 'no-touch' during liver transplantation for people with liver cancer (hepatocellular carcinoma). The goal is to see if it improves outcomes by minimizing tumor spread during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (hepatocellular carcinoma), confirmed by a scan or biopsy.
- You are getting a liver transplant from a deceased donor for the first time.
- You are not having a split-liver or multi-organ transplant.
- You are not having a second liver transplant.
- There is no evidence of tumor invasion into major veins (like the portal vein) on imaging.
- You can be followed up after the transplant for data collection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether liver transplantation is safe and effective for people with liver cancer that has spread into the bile ducts (tumor thrombus). It may help patients whose only treatment option is a transplant.
This trial studies how a whole-body PET/CT scan using a “tracer” called 18F-FDG can help decide which people with liver cancer (HCC) may benefit from a liver transplant. It may help the transplant team better sort out who is likely to do well after transplant.
This trial studies how well combining local treatments with targeted drugs and immunotherapy works for patients with liver cancer who are waiting for a transplant. It aims to see if this approach is safe and helps control the cancer.
This trial looks at how well certain initial treatments (like targeted therapy, immunotherapy, or liver-directed procedures) work in people with liver cancer who have not had surgery yet. It aims to see if these treatments can shrink the tumor enough to allow removal later.
This trial tests an immunotherapy “downstaging” plan to shrink hepatocellular carcinoma (a type of liver cancer) so it may become treatable with a liver transplant. You may be eligible if your cancer is beyond transplant limits but is still only in the liver, and you meet specific liver function and health requirements.
This trial tests whether giving chemotherapy directly into the liver blood supply before a liver transplant can help people with liver cancer that is beyond standard transplant criteria. It may help lower cancer risk around the time of transplant while keeping people healthy enough to receive the transplant.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.